Houston Institute for Clinical Research

Houston, Texas 77024

Use our guide to learn which trials are right for you!

We've found
4 trials
at this facility
RHEUMATOID ARTHRITIS Clinical Trial
Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Have Active Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Evaluation of the Long Term Safety, Tolerability and Efficacy of Two Dosing Regimens of Olokizumab (OKZ), in Subjects With Rheumatoid Arthritis (RA) Who Previously Completed 24 Weeks of Blinded Treatment in One of the Core Studies - CREDO 1, 2 or 3.
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials